August 4, 2016
Vivozon to Present Practical Methodology in Identifying Antionociceptive Multi-Target Drugs at Upcoming 10th Annual Pain Therapeutics Summit
As the steady decline of newly developed single-targeted drugs is becoming a challenge in the field, researchers are preferring to use a practical methodology in identifying antionociceptive multi-target drugs. The design of this approach allows for drugs to reflect multifactorial diseases caused by intricate networks of various mechanisms. A recent review on the revolutionary trend in pursuing multi-targeting drugs has been released by several researchers in the field of neuropathic pain.